Skip to content
April 24, 2024

Equity.Guru

Investment information for the new generation

Search

cannabinol

InMed Pharmaceuticals (IN.T) has filed clinical trial applications (CTAs) in Austria, Israel and Serbia as part of a phase 2 clinical trial of INM-755, the Company’s cannabinol cream used…